Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells.
NAR Cancer
; 4(1): zcac007, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35252869
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
NAR Cancer
Year:
2022
Type:
Article
Affiliation country:
United States